| Chijioke David Ukoha Jr, | |
|
2000 S Palestine St, Athens, TX 75751-5610 | |
| (903) 676-1000 | |
| Not Available |
| Full Name | Chijioke David Ukoha Jr |
|---|---|
| Gender | Male |
| Speciality | Internal Medicine |
| Experience | 6 Years |
| Location | 2000 S Palestine St, Athens, Texas |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1417445255 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 208M00000X | Hospitalist | T2518 (Texas) | Secondary |
| 207R00000X | Internal Medicine | T2518 (Texas) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Ut Health East Texas Athens Hospital | Athens, TX | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Stone Fort Inpatient Services Pllc | 2567743511 | 24 |
News Archive
As states and cities grapple with how to reopen businesses, schools, and other staples of everyday life amid surges in COVID-19 infections, Asst. Prof. Abhishek Nagaraj and a team of researchers across four universities are building an interactive website that shows how different policies affect employment and the number of deaths from the virus.
A smartphone application can help in screening for atrial fibrillation, according to late breaking results from the DIGITAL-AF study presented at ESC Congress.
Vertex Pharmaceuticals Incorporated announced today that the U.S. Food and Drug Administration (FDA) has accepted the New Drug Application (NDA) for telaprevir and granted the company's request for six-month Priority Review. Telaprevir is Vertex's lead medicine in development for people with genotype 1 chronic hepatitis C.
A study by Johns Hopkins researchers of more than 13,000 people has found that even after accounting for such risk factors as high blood pressure, high cholesterol and diabetes, so-called morbid obesity appears to stand alone as a standout risk for heart failure, but not for other major types of heart disease.
› Verified 9 days ago
| Entity Name | Texas Health Physicians Group |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1174573596 PECOS PAC ID: 4385535954 Enrollment ID: O20040323000759 |
News Archive
As states and cities grapple with how to reopen businesses, schools, and other staples of everyday life amid surges in COVID-19 infections, Asst. Prof. Abhishek Nagaraj and a team of researchers across four universities are building an interactive website that shows how different policies affect employment and the number of deaths from the virus.
A smartphone application can help in screening for atrial fibrillation, according to late breaking results from the DIGITAL-AF study presented at ESC Congress.
Vertex Pharmaceuticals Incorporated announced today that the U.S. Food and Drug Administration (FDA) has accepted the New Drug Application (NDA) for telaprevir and granted the company's request for six-month Priority Review. Telaprevir is Vertex's lead medicine in development for people with genotype 1 chronic hepatitis C.
A study by Johns Hopkins researchers of more than 13,000 people has found that even after accounting for such risk factors as high blood pressure, high cholesterol and diabetes, so-called morbid obesity appears to stand alone as a standout risk for heart failure, but not for other major types of heart disease.
› Verified 9 days ago
| Entity Name | Stone Fort Inpatient Services Pllc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1316481492 PECOS PAC ID: 2567743511 Enrollment ID: O20170105000860 |
News Archive
As states and cities grapple with how to reopen businesses, schools, and other staples of everyday life amid surges in COVID-19 infections, Asst. Prof. Abhishek Nagaraj and a team of researchers across four universities are building an interactive website that shows how different policies affect employment and the number of deaths from the virus.
A smartphone application can help in screening for atrial fibrillation, according to late breaking results from the DIGITAL-AF study presented at ESC Congress.
Vertex Pharmaceuticals Incorporated announced today that the U.S. Food and Drug Administration (FDA) has accepted the New Drug Application (NDA) for telaprevir and granted the company's request for six-month Priority Review. Telaprevir is Vertex's lead medicine in development for people with genotype 1 chronic hepatitis C.
A study by Johns Hopkins researchers of more than 13,000 people has found that even after accounting for such risk factors as high blood pressure, high cholesterol and diabetes, so-called morbid obesity appears to stand alone as a standout risk for heart failure, but not for other major types of heart disease.
› Verified 9 days ago
| Entity Name | Etmc Physician Group, Inc. |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1609382662 PECOS PAC ID: 4486915600 Enrollment ID: O20180305002106 |
News Archive
As states and cities grapple with how to reopen businesses, schools, and other staples of everyday life amid surges in COVID-19 infections, Asst. Prof. Abhishek Nagaraj and a team of researchers across four universities are building an interactive website that shows how different policies affect employment and the number of deaths from the virus.
A smartphone application can help in screening for atrial fibrillation, according to late breaking results from the DIGITAL-AF study presented at ESC Congress.
Vertex Pharmaceuticals Incorporated announced today that the U.S. Food and Drug Administration (FDA) has accepted the New Drug Application (NDA) for telaprevir and granted the company's request for six-month Priority Review. Telaprevir is Vertex's lead medicine in development for people with genotype 1 chronic hepatitis C.
A study by Johns Hopkins researchers of more than 13,000 people has found that even after accounting for such risk factors as high blood pressure, high cholesterol and diabetes, so-called morbid obesity appears to stand alone as a standout risk for heart failure, but not for other major types of heart disease.
› Verified 9 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Chijioke David Ukoha Jr, 306 Stonemeade Way, Coppell, TX 75019-2679 Ph: (214) 682-7634 | Chijioke David Ukoha Jr, 2000 S Palestine St, Athens, TX 75751-5610 Ph: (903) 676-1000 |
News Archive
As states and cities grapple with how to reopen businesses, schools, and other staples of everyday life amid surges in COVID-19 infections, Asst. Prof. Abhishek Nagaraj and a team of researchers across four universities are building an interactive website that shows how different policies affect employment and the number of deaths from the virus.
A smartphone application can help in screening for atrial fibrillation, according to late breaking results from the DIGITAL-AF study presented at ESC Congress.
Vertex Pharmaceuticals Incorporated announced today that the U.S. Food and Drug Administration (FDA) has accepted the New Drug Application (NDA) for telaprevir and granted the company's request for six-month Priority Review. Telaprevir is Vertex's lead medicine in development for people with genotype 1 chronic hepatitis C.
A study by Johns Hopkins researchers of more than 13,000 people has found that even after accounting for such risk factors as high blood pressure, high cholesterol and diabetes, so-called morbid obesity appears to stand alone as a standout risk for heart failure, but not for other major types of heart disease.
› Verified 9 days ago
Jay Takata, Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 901 S Palestine St, Athens, TX 75751 Phone: 903-677-3737 Fax: 903-677-6014 | |
Srikar Reddy Mapakshi, M.D. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 115 S Murchison St, Athens, TX 75751 Phone: 903-677-3737 Fax: 903-677-6014 | |
Mr. Ronald Dwayne Cates, MD PA Internal Medicine Medicare: Not Enrolled in Medicare Practice Location: 704 S Palestine, Athens, TX 75751 Phone: 903-675-1717 Fax: 903-675-3338 | |
Shawn Tai, M.D. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 115 Medical Cir Ste 106, Athens, TX 75751 Phone: 903-675-1322 Fax: 903-675-6743 | |
Dr. Steven Helf, MD Internal Medicine Medicare: Not Enrolled in Medicare Practice Location: 1505 State Highway 19 S, Athens, TX 75751 Phone: 903-675-1725 | |
Dr. Maung Maung Oo, M.D. Internal Medicine Medicare: Not Enrolled in Medicare Practice Location: 115 Medical Cir, Suite 106, Athens, TX 75751 Phone: 903-675-1322 Fax: 903-675-6743 | |
Michael C Tobes, MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 1212 S Palestine St, Athens, TX 75751 Phone: 903-675-6800 Fax: 903-670-1134 |